Erica G. is an experienced professional with a strong background in oncology diagnostics and precision medicine. Currently serving as an Oncology Diagnostic Liaison at Pfizer, Erica oversees the Pathology/Diagnostic Market and Access strategy across nine states, focusing on strengthening diagnostic pathways and educating pathologists on emerging biomarkers. Previously, as Director of Precision Medicine at Caris Life Sciences, Erica drove innovation in precision oncology through strategic partnerships and data analytics. Erica's earlier roles include Account Manager at Ortho Clinical Diagnostics and significant contributions in sales and business development in women's health at Progenity, Inc. and Quest Diagnostics. Erica's career began with entrepreneurial success as the founder of a digital fashion magazine and includes notable achievements in sales management at The Coca-Cola Company and in advertising sales early on at Houston Community Newspapers. Erica holds a Bachelor of Arts in Advertising & Public Relations from the University of Houston.